메뉴 건너뛰기




Volumn 53, Issue 1, 2003, Pages 40-43

In vitro release of felodipine from original brand and generic products

Author keywords

CAS 72509 76 3; Felodipine, controlled release, generic drugs, pharmacokinetics, tolerability; Modip , in vitro release

Indexed keywords

FELODIPINE;

EID: 0037241378     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1297068     Document Type: Article
Times cited : (3)

References (8)
  • 1
    • 0032886513 scopus 로고    scopus 로고
    • "Circadian" variation in cardiovascular events and implications for therapy?
    • Mulcahy, D., "Circadian" variation in cardiovascular events and implications for therapy? J. Cardiovasc. Pharmacol. 34 (Suppl. 2), S3 (1999)
    • (1999) J. Cardiovasc. Pharmacol. , vol.34 , Issue.SUPPL. 2
    • Mulcahy, D.1
  • 2
    • 0033006886 scopus 로고    scopus 로고
    • Circadian variation in cardiovascular events
    • Muller, J. E., Circadian variation in cardiovascular events. Am. J. Hypertens. 12, 35S (1999)
    • (1999) Am. J. Hypertens. , vol.12
    • Muller, J.E.1
  • 3
    • 0030889620 scopus 로고    scopus 로고
    • Therapeutic implications of the epidemiology and timing of myocardial infarction and other cardiovascular diseases
    • Flack, J. M., Yunis, C., Therapeutic implications of the epidemiology and timing of myocardial infarction and other cardiovascular diseases. J. Hum. Hypertens. 11, 23 (1997)
    • (1997) J. Hum. Hypertens. , vol.11 , pp. 23
    • Flack, J.M.1    Yunis, C.2
  • 4
    • 0032811393 scopus 로고    scopus 로고
    • 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension
    • Guidelines sub-committee of the World Health Organization
    • Chalmers, J., MacMahon, S., Mancia, G. et al., 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin. Exp. Hypertens. 21, 1009 (1999)
    • (1999) Clin. Exp. Hypertens. , vol.21 , pp. 1009
    • Chalmers, J.1    MacMahon, S.2    Mancia, G.3
  • 5
    • 0031950918 scopus 로고    scopus 로고
    • Role of trough to peak efficacy in the evaluation of antihypertensive therapy
    • Meredith, P. A., Role of trough to peak efficacy in the evaluation of antihypertensive therapy. J. Hypertens. (Suppl.) 16, S59 (1998)
    • (1998) J. Hypertens. (Suppl.) , vol.16
    • Meredith, P.A.1
  • 6
    • 0025369119 scopus 로고
    • Felodipine extended-release tablets once daily are equivalent to plain tablets twice daily in treating hypertension
    • Dutch Hospital Multicentre Group
    • Hart, W., Westberg, B., Felodipine extended-release tablets once daily are equivalent to plain tablets twice daily in treating hypertension. Dutch Hospital Multicentre Group. J. Cardiovasc. Pharmacol. 15 (Suppl. 4), S65 (1990)
    • (1990) J. Cardiovasc. Pharmacol. , vol.15 , Issue.SUPPL. 4
    • Hart, W.1    Westberg, B.2
  • 7
    • 0024819682 scopus 로고
    • Ambulatory blood pressure monitoring during sustained treatment with conventional and extended-release felodipine in mild-to-moderate hypertension
    • Porcellati, C., Verdecchia, P., Gatteschi, C. et al., Ambulatory blood pressure monitoring during sustained treatment with conventional and extended-release felodipine in mild-to-moderate hypertension. Eur. J. Clin. Pharmacol. 37, 555 (1989)
    • (1989) Eur. J. Clin. Pharmacol. , vol.37 , pp. 555
    • Porcellati, C.1    Verdecchia, P.2    Gatteschi, C.3
  • 8
    • 0028018425 scopus 로고
    • Evaluation of solubilizers in the drug release testing of hydrophilic matrix extended-release tablets of felodipine
    • Abrahamsson, B., Johansson, D., Torstensson, A. et al., Evaluation of solubilizers in the drug release testing of hydrophilic matrix extended-release tablets of felodipine. Pharm Res 11, 1093 (1994)
    • (1994) Pharm Res. , vol.11 , pp. 1093
    • Abrahamsson, B.1    Johansson, D.2    Torstensson, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.